amoxicillin-clavulanic acid
Sponsors
Teva Pharmaceuticals USA, Quanta Medical, Eskisehir Osmangazi University, Menzies School of Health Research, University Medical Centre Ljubljana
Conditions
Antibiotic Associated DiarrheaDiverticular SigmoïditisHealthyInfectious DiseaseOut-of-hospital Cardiac ArrestPneumoniaSurgery
Phase 1
Amoxicillin-Clavulanic Acid 400 Mg-57 mg Chewable Tablets Under Non-Fasting Conditions
CompletedNCT00836901
Start: 2003-09-30End: 2003-09-30Updated: 2024-08-21
Amoxicillin-Clavulanic Acid 400 Mg-57 mg Chewable Tablets Under Fasting Conditions
CompletedNCT00835705
Start: 2003-09-30End: 2003-09-30Updated: 2024-08-20
Phase 3
Phase 4
Effect of Lactobacillus Reuteri DSM 17938 to Prevent Antibiotic-associated Diarrhea in Children
CompletedNCT02765217
Start: 2017-06-01End: 2020-12-01Updated: 2021-02-15
Hospitalised Pneumonia With Extended Treatment (HOPE) Study
CompletedNCT02783859
Start: 2016-06-30End: 2022-12-31Updated: 2026-01-15
Prophylactic Antibiotics in Comatose Survivors of Out-of-hospital Cardiac Arrest
CompletedNCT02899507
Start: 2013-09-30End: 2015-04-30Updated: 2016-09-14
Effects of Phenoximethylpenicillin, Amoxicillin and Amoxicillin-clavulanic Acid on the Gut Microbiota
CompletedNCT04084106
Start: 2019-09-10End: 2022-11-11Updated: 2022-12-02